Global Nicotine Gum Market 2014-2018: Key Vendors are GlaxoSmithKline, Johnson and Johnson, Novartis and Reynolds American

http://photos.prnewswire.com/prnh/20130307/600769

Nicotine gum is a smoking cessation product that helps smokers to slowly overcome nicotine addiction. Nicotine is released by chewing the gum and is absorbed into the blood stream through the lining of the mouth, which helps smokers to slowly reduce their craving for nicotine. Nicotine gum helps the human body battle the strong urge for nicotine after reducing the number of cigarettes smoked. The gum is available in various dosages and can be consumed according to the level of addiction.

The analysts forecast the Global Nicotine Gum market will grow at a CAGR of 4.46 percent over the period 2013-2018.

This report covers the present scenario and the growth prospects of the Global Nicotine Gum market for the period 2014-2018. To calculate market size, the report considers revenue generated through the sales of nicotine gum. Nicotine gum is one form of nicotine replacement therapy. The other forms are nicotine lozenges and patches.

The report, the Global Nicotine Gum Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts.

Key Topics Covered:

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

04. Market Research Methodology

05. Introduction

06. World Cigarette Statistics: Per Capita Consumption Per Year

07. Market Landscape

08. Geographical Segmentation

09. Buying Criteria

10. NRT Products Price Comparison

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

18. Key Vendor Analysis

19. Other Prominent Vendors

20. Other Reports in this Series

Companies Mentioned:

For more information visit http://www.researchandmarkets.com/research/m98knz/global_nicotine

Media Contact: Laura Wood, +353-1-481-1716, [email protected]